keyword
MENU ▼
Read by QxMD icon Read
search

PMDD

keyword
https://www.readbyqxmd.com/read/29576358/a-lecithin-phosphatidylserine-and-phosphatidic-acid-complex-pas-reduces-symptoms-of-the-premenstrual-syndrome-pms-results-of-a-randomized-placebo-controlled-double-blind-clinical-trial
#1
Katja Schmidt, Nicole Weber, Meir Steiner, Nadin Meyer, Anne Dubberke, David Rutenberg, Juliane Hellhammer
BACKGROUND & AIMS: Many women experience emotional and physical symptoms around the time of ovulation and more so before menstruation interfering with their daily normal life also known as premenstrual syndrome (PMS). Recent observational data suggest that supplementation with Lipogen's phosphatidylserine (PS) and phosphatidic acid (PA) complex (PAS) alleviates these PMS symptoms. The aim of this study was to confirm these observations on the effects of PAS on PMS symptom severity within a controlled clinical trial setting...
April 2018: Clinical Nutrition ESPEN
https://www.readbyqxmd.com/read/29565636/semi-individualized-homeopathy-add-on-versus-usual-care-only-for-premenstrual-disorders-a-randomized-controlled-feasibility-study
#2
Christien T Klein-Laansma, Mats Jong, Cornelia von Hagens, Jean Pierre C H Jansen, Herman van Wietmarschen, Miek C Jong
OBJECTIVES: Premenstrual syndrome and premenstrual dysphoric disorder (PMS/PMDD) bother a substantial number of women. Homeopathy seems a promising treatment, but it needs investigation using reliable study designs. The feasibility of organizing an international randomized pragmatic trial on a homeopathic add-on treatment (usual care [UC] + HT) compared with UC alone was evaluated. DESIGN: A multicenter, randomized, controlled pragmatic trial with parallel groups...
March 22, 2018: Journal of Alternative and Complementary Medicine: Research on Paradigm, Practice, and Policy
https://www.readbyqxmd.com/read/29432986/premenstrual-dysphoric-disorder-and-suicide-attempts-as-a-correlation-among-women-in-reproductive-age
#3
Narges Shams-Alizadeh, Azad Maroufi, Mahsa Rashidi, Daem Roshani, Fariba Farhadifar, Habibolah Khazaie
AIM: Women likely attempt suicide more than men and sex hormones or menstrual cycle may be associated with female suicide attempts. There are debates regarding the correlation of premenstrual dysphoric disorder (PMDD) and suicidal behaviors. The objective of this study was to examine if PMDD was associated with suicidal attempts as sex hormones are contributed in its pathogenesis. METHODS: As a case-control study 120 fertile woman with regular menstrual cycles attempting suicide and admitted to a general hospital were compared with a matched control group of 120 women selected among those accompanying other patients in other wards...
February 2, 2018: Asian Journal of Psychiatry
https://www.readbyqxmd.com/read/29407746/premenstrual-appetite-and-emotional-responses-to-foods-among-women-with-premenstrual-dysphoric-disorder
#4
Ju-Yu Yen, Tai-Ling Liu, I-Ju Chen, Su-Yin Chen, Chih-Hung Ko
The aim of the study was to evaluate changes in late-luteal appetite for highly sweet (HS) and highly salty and fatty (HSF) foods in women with premenstrual dysphoric disorder (PMDD). After initial assessment in a psychiatric interview, the premenstrual symptoms screening tool (PSST) was used to identify women with moderate-to-severe premenstrual symptoms. Sixty-seven women with PMDD and 74 healthy controls were evaluated in the early-follicular and late-luteal (pre-menstrual) phases of the menstrual cycle...
January 30, 2018: Appetite
https://www.readbyqxmd.com/read/29298169/premenstrual-syndrome-evidence-based-evaluation-and-treatment
#5
Sarah M Appleton
Premenstrual dysphoric disorder (PMDD) is defined by both physical and psychiatric symptoms that impact a woman significantly during the luteal phase of her menstrual cycle. Diagnostic criteria for PMDD were firmly established in the Diagnostic and Statistical Manual of Mental Disorders V in 2013, but many patients fall short of the diagnosis while still appreciably affected by severe premenstrual symptoms. More recent and robust investigations have evaluated the efficacy of treatment ranging from serotonergic therapy to hormonal treatment as well as lifestyle and herbal remedies...
March 2018: Clinical Obstetrics and Gynecology
https://www.readbyqxmd.com/read/29215138/premenstrual-syndrome-and-premenstrual-dysphoric-disorders-among-jordanian-women
#6
Abla Albsoul-Younes, Eman Alefishat, Rana Abu Farha, Lina Tashman, Enas Hijjih, Rasha AlKhatib
PURPOSE: The aim of this study was to investigate the frequency, associated factors, and management approaches of premenstrual dysphoric disorder (PMDD) and premenstrual syndrome (PMS) in Jordanian women. DESIGN AND METHODS: Three hundred premenopausal women completed a self-administered questionnaire. FINDINGS: Moderate-severe PMS was reported by 29% of women, while 14% had PMDD. Younger unmarried women had the more severe condition. Herbal remedies and no medication were the most common approaches used to manage PMS/PMDD...
December 7, 2017: Perspectives in Psychiatric Care
https://www.readbyqxmd.com/read/29201937/variance-in-mood-symptoms-across-menstrual-cycles-implications-for-premenstrual-dysphoric-disorder
#7
Tierney K Lorenz, Amanda N Gesselman, Virginia J Vitzthum
Premenstrual dysphoric disorder (PMDD) remains a controversial diagnosis: Some authors have argued that it pathologizes normal mood changes, and others have questioned the need for daily mood reports across multiple cycles. In the present study, we examined changes in mood among psychologically healthy young participants with regular menstrual cycles. We collected daily reports of negative mood (depression, nervousness, irritability, and fatigue) across two to six consecutive cycles from 27 participants aged 18-35 years, and we used variance decomposition analyses to examine how much of the variance in these daily reports was due to day, cycle, and individual...
2017: Women's Reproductive Health
https://www.readbyqxmd.com/read/29146473/estrogen-levels-emotion-regulation-and-emotional-symptoms-of-women-with-premenstrual-dysphoric-disorder-the-moderating-effect-of-estrogen-receptor-1%C3%AE-polymorphism
#8
Ju-Yu Yen, Peng-Wei Wang, Chen-Hsiang Su, Tai-Ling Liu, Cheng-Yu Long, Chih-Hung Ko
BACKGROUND: This study evaluated the association between estrogen levels, emotion regulation, depression, anxiety, and stress of women with premenstrual dysphoric disorder (PMDD). We also evaluated the moderating effect of estrogen receptor (ESR) α-Xbal polymorphism on the aforementioned association. METHODS: A total of 100 women were diagnosed with PMDD based on psychiatric interviews and a prospective investigation of 3 menstrual cycles. A total of 96 normal individuals were recruited as controls...
March 2, 2018: Progress in Neuro-psychopharmacology & Biological Psychiatry
https://www.readbyqxmd.com/read/29145910/brain-activation-during-emotion-regulation-in-women-with-premenstrual-dysphoric-disorder
#9
Nicole Petersen, Dara G Ghahremani, Andrea J Rapkin, Steven M Berman, Letty Liang, Edythe D London
BACKGROUND: Difficulties in regulating emotions are linked to the core symptoms of premenstrual dysphoric disorder (PMDD). We therefore investigated the neural substrates of emotion-regulation problems in women with PMDD. METHODS: On the basis of self-evaluations over 2 months on the Daily Record of Severity of Problems, eligible participants were assigned to two groups: PMDD and control (18 per group). Functional magnetic resonance imaging (fMRI) and a well-validated task were used to assess brain function during emotion regulation...
November 17, 2017: Psychological Medicine
https://www.readbyqxmd.com/read/29132173/premenstrual-syndrome-diagnosis-a-comparative-study-between-the-daily-record-of-severity-of-problems-drsp-and-the-premenstrual-symptoms-screening-tool-psst
#10
Aline Henz, Charles Francisco Ferreira, Carolina Leão Oderich, Carin Weirich Gallon, Juliana Rintondale Sodré de Castro, Maiara Conzatti, Marcelo Pio de Almeida Fleck, Maria Celeste Osório Wender
OBJECTIVE:  To validate the premenstrual symptoms screening tool (PSST) in relation to the daily record of severity of problems (DRSP) for premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) diagnoses. METHODS:  A cross-sectional study with 127 women (20-45 years) with PMS complaints. The women were evaluated in terms of weight, height and body mass index (BMI). After using the primary care evaluation of mental disorders (PRIME-MD) questionnaire to exclude the diagnosis of depression, the PSST was completed and the women were instructed to fill out the DRSP for two consecutive menstrual cycles...
January 2018: Revista Brasileira de Ginecologia e Obstetrícia
https://www.readbyqxmd.com/read/29111950/methods-for-coping-with-premenstrual-change-development-and-validation-of-the-german-premenstrual-change-coping-inventory
#11
Gudrun Kaiser, Johanna N Kues, Maria Kleinstäuber, Gerhard Andersson, Cornelia Weise
During the premenstrual phase, psychological and physiological changes can occur, which are associated with different levels of disability. When they appear with Premenstrual Dysphoric Disorder (PMDD), different coping strategies may be used by women to deal with premenstrual changes. Currently no German measure exists for assessing premenstrual symptom-related coping strategies. Therefore, we developed the Premenstrual Change Coping Inventory (PMS-Cope). First, the 33-item questionnaire was tested with an exploratory factor analytic approach (EFA) in a sample of 150 women prospectively diagnosed with PMDD or severe Premenstrual Syndrome from August 2013 until March 2016...
November 7, 2017: Women & Health
https://www.readbyqxmd.com/read/29082433/reproductive-affective-disorders-a-review-of-the-genetic-evidence-for-premenstrual-dysphoric-disorder-and-postpartum-depression
#12
REVIEW
Katherine McEvoy, Lauren M Osborne, Julie Nanavati, Jennifer L Payne
PURPOSE OF REVIEW: The purpose of this study is to review and summarize the literature exploring the genetic basis for premenstrual dysphoric disorder (PMDD) and postpartum depression (PPD). RECENT FINDINGS: There is more evidence for a genetic basis for PPD than for PMDD, but only when PPD is defined as beginning in the immediate postpartum time period. Familial, genome-wide linkage and association studies, and candidate gene studies, most in the past 10 years, have examined the genetic etiology of reproductive affective disorders, including PMDD and PPD...
October 30, 2017: Current Psychiatry Reports
https://www.readbyqxmd.com/read/29072794/effects-of-gaba-active-steroids-in-the-female-brain-with-focus-on-the-premenstrual-dysphoric-disorder
#13
REVIEW
Marie Bixo, Maja Johansson, Erika Timby, Louise Michalski, Torbjörn Bäckström
PMDD (premenstrual dysphoric disorder) afflicts 3-5% of women of childbearing age, and is characterized by recurrent negative mood symptoms, e.g. irritability, depression, anxiety and emotional lability during the luteal phase of the menstrual cycle. The etiology of PMDD is unknown, but a temporal association with circulating ovarian steroids, in particular progesterone and its metabolite allopregnanolone, during the luteal phase has been established. Allopregnanolone is a positive modulator of the GABAA receptor: it is sedative in high concentrations, but may precipitate paradoxical adverse effects on mood at levels corresponding to luteal phase concentrations in susceptible women...
October 26, 2017: Journal of Neuroendocrinology
https://www.readbyqxmd.com/read/29063202/vitex-agnus-castus-for-premenstrual-syndrome-and-premenstrual-dysphoric-disorder-a-systematic-review
#14
REVIEW
Raphael O Cerqueira, Benicio N Frey, Emilie Leclerc, Elisa Brietzke
The objective of this study was to evaluate whether Vitex agnus castus is a safe and effective treatment for PMS and premenstrual dysphoric disorder (PMDD) and to discuss the implications of these findings for clinical practice. A systematic review of literature was conducted using PubMed and Scielo databases. The inclusion criteria were randomized controlled trials (RCT) using V. agnus castus in individuals with PMS or PMDD that compared this intervention with placebo or an active comparator and included a description of blinding and dropouts/withdrawals...
December 2017: Archives of Women's Mental Health
https://www.readbyqxmd.com/read/29032438/improvements-in-quality-adjusted-life-years-and-cost-utility-after-pharmacotherapy-for-premenstrual-dysphoric-disorder-a-retrospective-study
#15
Eiichiro Kamagata, Kazuo Yamada
BACKGROUND AND OBJECTIVE: To investigate the cost-effectiveness of pharmacotherapy for premenstrual dysphoric disorder (PMDD), a relatively new classification of depressive disorder that is characterized by recurrent depression during the premenstrual phase of the menstrual cycle. METHODS: We performed a retrospective analysis of data from 49 previously untreated PMDD patients who visited our psychiatric department between October 2013 and February 2016 and received pharmacotherapy for 3 or 6 subsequent menstrual cycles...
January 2018: Clinical Drug Investigation
https://www.readbyqxmd.com/read/28966755/premenstrual-syndrome-symptomatic-and-diagnosed-prevalence-dualistic-treatment-approach-a-cross-sectional-study-in-ukraine
#16
Edith Meszaros Crow, Emilien Jeannot
BACKGROUND: Diagnosing and treatment of premenstrual syndrome (PMS) still pose a challenge in the routine medical practice which usually focuses on single pharmacological therapy. Recent research suggests that the combination of treatments including complementary alternative medicine (CAM) therapies may be more beneficial. The objective of this study was to assess the percentage of diagnosed and nondiagnosed PMS/premenstrual dysphoric disorder (PMDD) based on the presence of adequate symptoms and to compare population using hormonal or pharmaceutical agents versus CAM therapies...
2017: International Journal of Preventive Medicine
https://www.readbyqxmd.com/read/28965460/for-women-with-pmdd-acute-changes-in-ovarian-steroids-but-not-enduring-higher-levels-precipitate-symptoms
#17
EDITORIAL
Barbara L Parry
No abstract text is available yet for this article.
October 1, 2017: American Journal of Psychiatry
https://www.readbyqxmd.com/read/28930142/study-protocol-for-a-randomized-double-blind-treatment-control-trial-comparing-the-efficacy-of-a-micronutrient-formula-to-a-single-vitamin-supplement-in-the-treatment-of-premenstrual-syndrome
#18
Hannah Retallick-Brown, Julia Rucklidge, Neville Blampied
Background: The recent addition of Premenstrual Dysphoric Disorder (PMDD) to the Diagnostic and Statistical Manual (5th ed.) has highlighted the seriousness of this disorder. Many alternatives to psychoactive medication in the form of vitamins, minerals, and plant extracts have been trialled by women seeking a natural treatment approach. We plan to explore whether a well validated micronutrient formula, EMPowerplus Advanced, can outperform a recognized single nutrient treatment, vitamin B6, for the treatment of Premenstrual Syndrome (PMS)...
December 7, 2016: Medicines (Basel, Switzerland)
https://www.readbyqxmd.com/read/28882775/premenstrual-dysphoric-disorder-in-a-patient-with-traumatic-brain-injury-a-case-presentation
#19
Jaclyn Omura, Marisa Osorio
We present a case of a 17-year-old girl who developed premenstrual dysphoric disorder (PMDD) after sustaining a severe traumatic brain injury (TBI), and we review the diagnosis of PMDD. The patient developed symptoms of severe depression surrounding her menses months after sustaining severe TBI and was diagnosed with PMDD by a psychiatrist. She ultimately required antipsychotics for optimal symptom resolution. PMDD is a severe form of premenstrual syndrome with symptoms including irritability, anxiety, and nonfatal suicidal behavior...
September 4, 2017: PM & R: the Journal of Injury, Function, and Rehabilitation
https://www.readbyqxmd.com/read/28846801/increased-illness-burden-in-women-with-comorbid-bipolar-and-premenstrual-dysphoric-disorder-data-from-1-099-women-from-step-bd-study
#20
A Slyepchenko, B N Frey, B Lafer, A A Nierenberg, G S Sachs, R S Dias
BACKGROUND: The impact of comorbid premenstrual dysphoric disorder (PMDD) in women with bipolar disorder (BD) is largely unknown. AIMS: We compared illness characteristics and female-specific mental health problems between women with BD with and without PMDD. MATERIALS & METHODS: A total of 1 099 women with BD who participated in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) were studied. Psychiatric diagnoses and illness characteristics were assessed using the Mini International Neuropsychiatric Interview...
November 2017: Acta Psychiatrica Scandinavica
keyword
keyword
26920
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"